Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

Author： Ghossein R.A.   Rosai J.   Scher H.I.   Seiden M.   Zhang Z.-F.   Sun M.   Chang G.   Berlane K.   Krithivas K.   Kantoff P.W.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.50, Iss.1, 1997-07, pp. : 100-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer

By Kiper Ahmet   Yiğitbası Orhan   Imamoglu Abdurrahim   Tuygun Can   Turan Celaleddin  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 571-576

Springer Publishing Company

Access to resources Recommend Favorite

Tissue Polypeptide-Specific Antigen (TPS) Determinations before and during Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostatic Carcinoma

By Kil P.J.M.   Goldschmidt H.M.J.   Wieggers B.J.A.   Kariakine O.B.   Studer U.E.   Whelan P.   Hetherington J.   de Reijke T.M.   Hoekstra J.W.   Collette L.  

European Urology, Vol. 43, Iss. 1, 2003-01 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era

By Oefelein M.G.   Ricchiuti V.S.   Conrad P.W.   Goldman H.   Bodner D.   Resnick M.I.   Seftel A.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 120-124

Elsevier

Access to resources Recommend Favorite

Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer - a marker of androgen-independent (AI) growth in prostatic carcinoma (PC).(abstract)

By Veltri R.W.   Miller M.C.   Zhao G.   Ng A.   Marley G.M.   Wright G.L.   Vessella R.L.   Ralph D.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 139-147

Elsevier

Access to resources Recommend Favorite